Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor
- PMID: 3110627
- DOI: 10.1038/328260a0
Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor
Abstract
CD4 is a molecule expressed on the surface of T lymphocytes which recognize foreign protein antigens in the context of class II major histocompatibility complex (MHC) molecules. Recognition of antigen:class II MHC complexes by CD4+ T cells can be inhibited by anti-CD4 (ref. 3). Nevertheless, specific recognition of the antigen:Ia complex is clearly a function of the T-cell receptor, which is composed of CD3 and the variable polypeptides alpha and beta. Thus, it has been proposed that CD4 serves an accessory function in the interaction of CD4+ T cells and Ia-bearing antigen-presenting cells by binding to non-polymorphic portions of class II MHC molecules and stabilizing the cell interaction. Based on our observation that anti-CD4 could inhibit activation of a cloned line of CD4+ T cells by antibodies directed at a particular epitope on the variable region of the T-cell receptor, we have recently proposed that CD4 is actually part of the T-cell antigen recognition complex, physically associated with CD3:alpha:beta. But numerous studies showing that CD3 and CD4 are not stably associated on the T-cell surface would appear to contradict this model. Here we show that anti-T-cell-receptor antibodies can co-modulate expression of the T-cell receptor and CD4, and that the monovalent Fab fragment of such an anti-T-cell-receptor antibody can, in conjunction with bivalent anti-CD4 antibody, generate an activating signal for the T cell. These findings provide further evidence for a physical association of the T-cell receptor complex and CD4.
Similar articles
-
CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.Immunology. 1989 Sep;68(1):1-6. Immunology. 1989. PMID: 2530152 Free PMC article.
-
T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor.J Immunol. 1992 Mar 15;148(6):1643-51. J Immunol. 1992. PMID: 1531842
-
The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies.J Mol Cell Immunol. 1987;3(2):121-31. J Mol Cell Immunol. 1987. PMID: 2978238
-
Immune recognition and effector function in subsets of CD4 T cells.Princess Takamatsu Symp. 1988;19:193-208. Princess Takamatsu Symp. 1988. PMID: 2908353 Review.
-
The co-receptor function of CD4.Semin Immunol. 1991 May;3(3):153-60. Semin Immunol. 1991. PMID: 1716173 Review.
Cited by
-
T cell targeting in cancer therapy.Cancer Immunol Immunother. 1991;34(1):1-8. doi: 10.1007/BF01741317. Cancer Immunol Immunother. 1991. PMID: 1760806 Free PMC article. Review.
-
Association of CD8 with p56lck is required for early T cell signalling events.EMBO J. 1991 May;10(5):1201-7. doi: 10.1002/j.1460-2075.1991.tb08061.x. EMBO J. 1991. PMID: 1902413 Free PMC article.
-
Anti-L3T4 antibody inhibits the lysis of H-2 class II antigen-negative target cells by L3T4+ cytotoxic T lymphocytes.Proc Natl Acad Sci U S A. 1988 Jul;85(14):5205-9. doi: 10.1073/pnas.85.14.5205. Proc Natl Acad Sci U S A. 1988. PMID: 2839834 Free PMC article.
-
Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen-specific T helper clones. T cell receptor/CD3 complex transmits CD4-dependent and CD4-independent signals.J Clin Invest. 1992 Jun;89(6):1807-16. doi: 10.1172/JCI115785. J Clin Invest. 1992. PMID: 1534818 Free PMC article.
-
Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.Infect Immun. 1995 Feb;63(2):423-9. doi: 10.1128/iai.63.2.423-429.1995. Infect Immun. 1995. PMID: 7822006 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials